https://www.selleckchem.com/products/cpi-613.html
coli MurA inhibiting potential. Recent trials suggest glucagon-like peptide-1 receptor agonists (GLP-1RAs) may have a cardioprotective role by reducing major adverse cardiac events, stroke mortality and heart failure-related hospitalisations. We examined whether and how GLP-1RAs affect cardiac function in cardiovascular and metabolic diseases including type 2 diabetes, heart failure and post-myocardial infarction. In this PRISMA-adherent systematic review and meta-analysis, three databases were searched from inception to July 2021 and r
Мне нравится
Комментарий
Перепост
